Lates News

Chang Feng Pharmaceuticals plans to raise 607.67 million Hong Kong dollars in its IPO in Hong Kong, intending to sell 41.2 million shares at a price of 14.75 Hong Kong dollars per share. Chang Feng Pharmaceuticals expects the shares to start trading on the Hong Kong Stock Exchange on October 8th.